
On Sunday evening, Benzinga asked its followers on Twitter what they’re buying at the open on Monday. From the replies Benzinga selected one ticker for technical analysis.
@Williamdontkno1, @Natronrz and @getsumgetright are buying Clarus Therapeutics Holdings, Inc (NASDAQ:CRXT).